131 related articles for article (PubMed ID: 6373477)
1. Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.
Hattori K; Hasumura Y; Takeuchi J
Gastroenterol Jpn; 1984 Feb; 19(1):59-64. PubMed ID: 6373477
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin and glucagon on serum amino acid concentrations in liver disease.
Watanabe A; Higashi T; Hayashi S; Obata T; Sakata T; Takei N; Shiota T; Nagashima H
Acta Med Okayama; 1982 Dec; 36(6):441-6. PubMed ID: 6760674
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
4. Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject.
Kolanowski J; Salvador G; Desmecht P; Henquin JC; Crabbé J
Eur J Clin Invest; 1977 Jun; 7(3):167-75. PubMed ID: 408142
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative glucagon-insulin therapy on the patient with hepatic failure secondary to combined valvular disease].
Kumagae T; Morishita Y; Yuda T; Shimokawa S; Umebayashi Y; Higashi T; Taira A
Kyobu Geka; 1984 Aug; 37(9 Suppl):732-5. PubMed ID: 6389951
[No Abstract] [Full Text] [Related]
6. Effects of somatostatin on renal function in cirrhosis.
Ginès A; Salmerón JM; Ginès P; Jiménez W; Saló J; Piera C; Clària J; Rivera F; Arroyo V; Rodés J
Gastroenterology; 1992 Dec; 103(6):1868-74. PubMed ID: 1360435
[TBL] [Abstract][Full Text] [Related]
7. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.
Ginès A; Salmerón JM; Ginès P; Arroyo V; Jiménez W; Rivera F; Rodés J
J Hepatol; 1993 Feb; 17(2):220-6. PubMed ID: 8445236
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
[TBL] [Abstract][Full Text] [Related]
9. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
10. Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
Fernández-Varo G; Ros J; Cejudo-Martín P; Cano C; Arroyo V; Rivera F; Rodés J; Jiménez W
J Hepatol; 2003 Jun; 38(6):755-61. PubMed ID: 12763368
[TBL] [Abstract][Full Text] [Related]
11. Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading.
Caregaro L; Lauro S; Angeli P; Merkel C; Gatta A
Eur J Clin Invest; 1985 Dec; 15(6):360-4. PubMed ID: 3938405
[TBL] [Abstract][Full Text] [Related]
12. Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.
Fouad YM; Mokarrab H; Elgebaly AF; El-Amin H; Abdel-Raheem EM; Sharawy MA; Shatat ME
Trop Gastroenterol; 2009; 30(4):213-8. PubMed ID: 20426281
[TBL] [Abstract][Full Text] [Related]
13. Renal and hormonal responses to repeated treatment with enalapril in non-azotemic cirrhosis with ascites.
Ohnishi A; Murakami S; Harada M; Osaka K; Wada K; Odagiri M; Tsuchiya T; Tanaka T
J Hepatol; 1994 Feb; 20(2):223-30. PubMed ID: 8006403
[TBL] [Abstract][Full Text] [Related]
14. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
Hattori K; Hasumura Y; Takeuchi J
Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
[TBL] [Abstract][Full Text] [Related]
15. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Leehey DJ; Gollapudi P; Deakin A; Reid RW
J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
Wong F; Logan A; Blendis L
Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
[TBL] [Abstract][Full Text] [Related]
17. Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion.
Gentilini P; Laffi G; Fantini F; di Donato M; Dabizzi RP; La Villa G; Pinzani M; Buzzelli G; Smorlesi C; Pampana A
Digestion; 1983; 27(3):138-45. PubMed ID: 6195037
[TBL] [Abstract][Full Text] [Related]
18. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
Rector WG
Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of atrial natriuretic peptide in patients with liver cirrhosis and its relation to ascites and renal function.
Fukui H; Tsujii T; Matsumura M; Okamoto S; Morita T; Koizumi M; Morimura M; Kojima H; Hokaze Y; Fujimoto M
Gastroenterol Jpn; 1989 Apr; 24(2):149-55. PubMed ID: 2526038
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
